Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart
ABSTRACT:: The mitogen-activated protein kinases (MAPKs) play an important role in ischemia/reperfusion (I/R) injury. Previous evidence suggests that p38 MAPK inhibition before ischemia is cardioprotective. However, whether p38 MAPK inhibition during ischemia or reperfusion provides cardioprotection...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.ncbi.nlm.nih.gov/pubmed/23107875 http://www.scopus.com/inward/record.url?eid=2-s2.0-84873407517&partnerID=40&md5=3e12fc367ae1dcd2c6024e96a30e3675 http://cmuir.cmu.ac.th/handle/6653943832/3995 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
id |
th-cmuir.6653943832-3995 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-39952014-08-30T02:35:33Z Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart Surinkaew S. Kumphune S. Chattipakorn S. Chattipakorn N. ABSTRACT:: The mitogen-activated protein kinases (MAPKs) play an important role in ischemia/reperfusion (I/R) injury. Previous evidence suggests that p38 MAPK inhibition before ischemia is cardioprotective. However, whether p38 MAPK inhibition during ischemia or reperfusion provides cardioprotection is not well known. We tested the hypothesis that p38 MAPK inhibition at different times during I/R protects the heart from arrhythmias, reduces the infarct size, and attenuates ventricular dysfunction. Adult Wistar rats were subject to a 30-minute left anterior descending coronary artery occlusion, followed by a 120-minute reperfusion. A p38 MAPK inhibitor, SB203580, was given intravenously before left anterior descending coronary artery occlusion, during ischemia, or at the onset of reperfusion. The results showed that SB203580 given either before or during ischemia, but not at the onset of reperfusion, decreased the ventricular tachycardia/ventricular fibrillation (VT/VF) incidence and heat shock protein 27 phosphorylation, and increased connexin 43 phosphorylation. The infarct size and cytochrome c level was decreased in all SB203580-treated rats, without the alteration of the total Bax/Bcl-2 expression. The ventricular function was improved only in SB203580-pretreated rats. These findings suggest that timing of p38 MAPK inhibition with respect to onset of ischemia is an important determinant of therapeutic efficacy. Copyright © 2013 by Lippincott Williams & Wilkins. 2014-08-30T02:35:33Z 2014-08-30T02:35:33Z 2013 Article 01602446 10.1097/FJC.0b013e318279b7b1 23107875 JCPCD http://www.ncbi.nlm.nih.gov/pubmed/23107875 http://www.scopus.com/inward/record.url?eid=2-s2.0-84873407517&partnerID=40&md5=3e12fc367ae1dcd2c6024e96a30e3675 http://cmuir.cmu.ac.th/handle/6653943832/3995 English |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
language |
English |
description |
ABSTRACT:: The mitogen-activated protein kinases (MAPKs) play an important role in ischemia/reperfusion (I/R) injury. Previous evidence suggests that p38 MAPK inhibition before ischemia is cardioprotective. However, whether p38 MAPK inhibition during ischemia or reperfusion provides cardioprotection is not well known. We tested the hypothesis that p38 MAPK inhibition at different times during I/R protects the heart from arrhythmias, reduces the infarct size, and attenuates ventricular dysfunction. Adult Wistar rats were subject to a 30-minute left anterior descending coronary artery occlusion, followed by a 120-minute reperfusion. A p38 MAPK inhibitor, SB203580, was given intravenously before left anterior descending coronary artery occlusion, during ischemia, or at the onset of reperfusion. The results showed that SB203580 given either before or during ischemia, but not at the onset of reperfusion, decreased the ventricular tachycardia/ventricular fibrillation (VT/VF) incidence and heat shock protein 27 phosphorylation, and increased connexin 43 phosphorylation. The infarct size and cytochrome c level was decreased in all SB203580-treated rats, without the alteration of the total Bax/Bcl-2 expression. The ventricular function was improved only in SB203580-pretreated rats. These findings suggest that timing of p38 MAPK inhibition with respect to onset of ischemia is an important determinant of therapeutic efficacy. Copyright © 2013 by Lippincott Williams & Wilkins. |
format |
Article |
author |
Surinkaew S. Kumphune S. Chattipakorn S. Chattipakorn N. |
spellingShingle |
Surinkaew S. Kumphune S. Chattipakorn S. Chattipakorn N. Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart |
author_facet |
Surinkaew S. Kumphune S. Chattipakorn S. Chattipakorn N. |
author_sort |
Surinkaew S. |
title |
Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart |
title_short |
Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart |
title_full |
Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart |
title_fullStr |
Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart |
title_full_unstemmed |
Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart |
title_sort |
inhibition of p38 mapk during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart |
publishDate |
2014 |
url |
http://www.ncbi.nlm.nih.gov/pubmed/23107875 http://www.scopus.com/inward/record.url?eid=2-s2.0-84873407517&partnerID=40&md5=3e12fc367ae1dcd2c6024e96a30e3675 http://cmuir.cmu.ac.th/handle/6653943832/3995 |
_version_ |
1681420153851478016 |